These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12838495)

  • 21. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
    Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
    PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
    Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
    Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L
    Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.
    Fujinaga S; Ohtomo Y; Umino D; Takemoto M; Shimizu T; Yamashiro Y; Kaneko K
    Pediatr Nephrol; 2007 Jan; 22(1):71-6. PubMed ID: 17086405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving long-term outcomes in idiopathic membranous nephropathy using a distinctive cyclosporine regimen.
    Hassan K; Kristal B
    Minerva Urol Nefrol; 2016 Jun; 68(3):293-301. PubMed ID: 25645342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
    Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
    BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy.
    Matsumoto H; Nagaoka Y; Okada T; Wada T; Gondo A; Esaki S; Hayashi A; Miyaoka Y; Nakao T
    Intern Med; 2011; 50(18):1905-10. PubMed ID: 21921367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
    Geng HY; Ji LN; Chen CY; Tu J; Li HR; Bao R; Lin Y
    Zhonghua Er Ke Za Zhi; 2018 Sep; 56(9):651-656. PubMed ID: 30180402
    [No Abstract]   [Full Text] [Related]  

  • 30. Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience.
    Katsuno T; Ozaki T; Kim H; Kato N; Suzuki Y; Akiyama S; Ishimoto T; Kosugi T; Tsuboi N; Ito Y; Maruyama S
    Intern Med; 2017; 56(13):1679-1686. PubMed ID: 28674357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycophenolate Mofetil with Steroid, a Reasonable Alternative to Current First-line Therapy, for Idiopathic Membranous Nephropathy in Resource-constrained Settings: A Randomized, Open-label Study.
    Sharma M; Roy A; Doley PK; Pegu G
    J Assoc Physicians India; 2024 Jun; 72(6):15-19. PubMed ID: 38881128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
    Fujinaga S; Ohtomo Y; Hirano D; Nishizaki N; Someya T; Ohtsuka Y; Kaneko K; Shimizu T
    Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mofetil, an alternative to cyclosporine A for long-term immunosuppression in kidney transplantation?
    Houde I; Isenring P; Boucher D; Noël R; Lachanche JG
    Transplantation; 2000 Oct; 70(8):1251-3. PubMed ID: 11063351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early initiation of immunosuppressive treatment in membranous nephropathy patients.
    Chan CK; Lai TS; Chen PM; Chou YH; Wu CF; Chiu YL; Chiang WC; Chen YM; Chu TS; Wu KD
    J Formos Med Assoc; 2017 Apr; 116(4):266-275. PubMed ID: 28202222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
    Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
    Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
    Kalliakmani P; Koutroulia E; Sotsiou F; Vlachojannis JG; Goumenos DS
    Nephrology (Carlton); 2010 Dec; 15(8):762-7. PubMed ID: 21175962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study.
    Potena L; Prestinenzi P; Bianchi IG; Masetti M; Romani P; Magnani G; Fallani F; Coccolo F; Russo A; Ponticelli C; Rapezzi C; Grigioni F; Branzi A
    J Heart Lung Transplant; 2012 Jun; 31(6):565-70. PubMed ID: 22341702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
    Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What have we learned from the use of ciclosporin A in the treatment of nephrotic patients with idiopathic membranous nephropathy?
    Goumenos DS
    Expert Opin Pharmacother; 2008 Jul; 9(10):1695-704. PubMed ID: 18570603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.